Tag Archives: cystic fibrosis

At the beginning of February, we took a look at development stage biotech company Pulmatrix Inc (NASDAQ:PULM) as part of this piece.  At the time, the company had just run up to the tune of 130% on the back of an expedited approval process...

At the beginning of this week, we highlighted Protalix Biotherapeutics Inc (NYSEMKT:PLX) as being a company to keep an eye on, with the highlighting rooted in the fact that management was set to hold a conference call on the back of its full-year...

Make a list of top performing biotech stocks of 2017 year to date, and Protalix Biotherapeutics Inc (NYSEMKT:PLX) is at or near the top. The company currently trades for around $1.20 a pop, having kicked off 2017 at circa $0.40 – a nearly...

On Monday, February 13, 2017, Protalix Biotherapeutics Inc (NYSEMKT:PLX) announced that it would be presenting at the 13th Annual WORLDSymposium 2017 in California. On the back of the announcement, the company gained just short of 30%, and...

At the beginning of January, we looked at Protalix Biotherapeutics Inc (NYSEMKT:PLX), in this piece. At that time, our thesis was simple, and our reason for highlighting the company – even simpler. Basically, we thought that the company was...

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) plunged into the close of 2016, and hasn’t been able to stage any degree of recovery throughout early 2017. The company fell foul of some negative data surrounding its lead asset in December,...

Protalix Biotherapeutics Inc (NYSEMKT:PLX) is getting beaten down despite just putting out some positive interim data, and we believe this is a serious misinterpretation of the news; that, or the company is being completely overlooked by the...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter